Chicoric acid ameliorates sepsis-induced cardiomyopathy via regulating macrophage metabolism reprogramming

Sepsis-related cardiac dysfunction is believed to be a primary cause of high morbidity and mortality. Metabolic reprogramming is closely linked to NLRP3 inflammasome activation and dysregulated glycolysis in activated macrophages, leading to inflammatory responses in septic cardiomyopathy. Succinate...

Full description

Saved in:
Bibliographic Details
Published in:Phytomedicine (Stuttgart) 2024-01, Vol.123, p.155175-155175, Article 155175
Main Authors: Sun, Hai-Jian, Zheng, Guan-Li, Wang, Zi-Chao, Liu, Yao, Bao, Neng, Xiao, Ping-Xi, Lu, Qing-Bo, Zhang, Ji-Ru
Format: Article
Language:English
Subjects:
Caffeic Acids
Cardiomyopathies - drug therapy
Cardiomyopathies - etiology
Humans
Inflammasomes - metabolism
Lipopolysaccharides - adverse effects
Macrophages - metabolism
Metabolic Reprogramming
NLR Family, Pyrin Domain-Containing 3 Protein - metabolism
Sepsis - complications
Sepsis - drug therapy
Succinates - adverse effects
Succinic Acid - adverse effects
Tubulin - metabolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Sepsis-related cardiac dysfunction is believed to be a primary cause of high morbidity and mortality. Metabolic reprogramming is closely linked to NLRP3 inflammasome activation and dysregulated glycolysis in activated macrophages, leading to inflammatory responses in septic cardiomyopathy. Succinate dehydrogenase (SDH) and succinate play critical roles in the progression of metabolic reprogramming in macrophages. Inhibition of SDH may be postulated as an effective strategy to attenuate macrophage activation and sepsis-induced cardiac injury. This investigation was designed to examine the role of potential compounds that target SDH in septic cardiomyopathy and the underlying mechanisms involved. From a small molecule pool containing about 179 phenolic compounds, we found that chicoric acid (CA) had the strongest ability to inhibit SDH activity in macrophages. Lipopolysaccharide (LPS) exposure stimulated SDH activity, succinate accumulation and superoxide anion production, promoted mitochondrial dysfunction, and induced the expression of hypoxia-inducible factor-1α (HIF-1α) in macrophages, while CA ameliorated these changes. CA pretreatment reduced glycolysis by elevating the NAD /NADH ratio in activated macrophages. In addition, CA promoted the dissociation of K(lysine) acetyltransferase 2A (KAT2A) from α-tubulin, and thus reducing α-tubulin acetylation, a critical event in the assembly and activation of NLRP3 inflammasome. Overexpression of KAT2A neutralized the effects of CA, indicating that CA inactivated NLRP3 inflammasome in a specific manner that depended on KAT2A inhibition. Importantly, CA protected the heart against endotoxin insult and improved sepsis-induced cardiac mitochondrial structure and function disruption. Collectively, CA downregulated HIF-1α expression via SDH inactivation and glycolysis downregulation in macrophages, leading to NLRP3 inflammasome inactivation and the improvement of sepsis-induced myocardial injury. These results highlight the therapeutic role of CA in the resolution of sepsis-induced cardiac inflammation.
ISSN:0944-7113
1618-095X
DOI:10.1016/j.phymed.2023.155175